Evidence-based optimal fluconazole dosing regimen for onychomycosis treatment.
about
Network Meta-Analysis of Onychomycosis TreatmentsSpotlight on tavaborole for the treatment of onychomycosisOnychomycosis in the 21st Century: An Update on Diagnosis, Epidemiology, and Treatment.Investigational drugs for onychomycosis.Improving Cure Rates in Onychomycosis.Novel pyrazine analogs of chalcones: synthesis and evaluation of their antifungal and antimycobacterial activity.Onychomycosis: A Review.
P2860
Q26750479-69871D39-3680-4A22-8EC2-D2192A82FA2BQ26774184-61218E6A-0C5A-4A7B-8163-0A84FB2DC500Q36412047-02E799D9-F2F7-4606-9A34-BE396F18E085Q38144164-53497CDF-79CD-40F5-BDC8-D495B70E9A7FQ38867934-84A92BE5-5A12-498D-B9D9-11735421A6A0Q41545511-D64D4094-D2EE-4FB8-9C40-A76F435DE474Q48149284-6477FCF5-BCBC-419D-9C6E-BBD0469E223A
P2860
Evidence-based optimal fluconazole dosing regimen for onychomycosis treatment.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Evidence-based optimal fluconazole dosing regimen for onychomycosis treatment.
@en
type
label
Evidence-based optimal fluconazole dosing regimen for onychomycosis treatment.
@en
prefLabel
Evidence-based optimal fluconazole dosing regimen for onychomycosis treatment.
@en
P2860
P1476
Evidence-based optimal fluconazole dosing regimen for onychomycosis treatment.
@en
P2093
Chris Drummond-Main
Maryse Paquet
P2860
P356
10.3109/09546634.2012.703308
P577
2012-07-25T00:00:00Z